Robuta

https://www.clinicaltrialsarena.com/uncategorized/newsspinifex-phase-ii-ema401-trial-meets-primary-endpoint/ Spinifex Phase II EMA401 trial meets primary endpoint - Clinical Trials Arena Mar 20, 2023 - Spinifex Pharmaceuticals, an Australian pain drug development company, has reported that the Phase II trial of EMA401, for the treatment of postherpetic... phase iiprimary endpointclinical trialsspinifexmeets https://www.consultantlive.com/view/victorion-difference-inclisiran-achieves-primary-endpoint-of-ldl-c-reduction-versus-placebo VICTORION-Difference: Inclisiran Achieves Primary Endpoint of LDL-C Reduction Versus Placebo Patients with hypercholesterolemia on individualized maximally tolerated dose of statins achieved guideline-recommended LDL-C levels on inclisiran. primary endpointdifferenceldlreductionversus https://flcube.com/?p=38209 Eli Lilly's Jaypirca Achieves Primary Endpoint in Phase III BRUIN CLL-314 Trial - Insight, China's... eli lillyprimary endpointphase iiibruincll https://reachmd.com/news/darvadstrocel-misses-primary-endpoint-in-admire-cd-ii-trial/2486932/ Darvadstrocel Misses Primary Endpoint in ADMIRE CD II Trial - Be part of the knowledge - ReachMD Key Takeaways Week-24 combined remission was similar between darvadstrocel and placebo, and the primary endpoint was not met. Key secondary efficacy measures,... primary endpointpart ofthe knowledgemissesadmire https://www.medicaldevice-network.com/news/newssphere-medicals-proxima-blood-analyser-meets-primary-endpoint/ Sphere Medical's Proxima blood analyser meets primary endpoint - Medical Device Network Nov 25, 2011 - Sphere Medical's Proxima Generation 2 has met its primary endpoint in a multicentre clinical trial conducted at two UK hospitals, Queen Elizabeth Hospital... primary endpointspheremedicalproximablood https://ogkologos.com/phase-ii-lcmc3-study-of-neoadjuvant-atezolizumab-met-primary-endpoint-with-a-major-pathological-response-rate-of-20-in-resectable-stage-ib-iiib-nsclc/ Phase II LCMC3 Study of Neoadjuvant Atezolizumab Met Primary Endpoint with a Major Pathological... phase iiprimary endpointstudymetmajor https://markets.businessinsider.com/news/stocks/angiodynamics-meets-primary-endpoint-in-preserve-study-1034930536 AngioDynamics meets primary endpoint in PRESERVE study | Markets Insider AngioDynamics (ANGO) announced the publication of results from the PRESERVE study in the journal European Urology. The study assessed the safety... primary endpointmarkets insiderangiodynamicsmeetspreserve https://www.panabee.com/news/biontech-adc-trastuzumab-pamirtecan-hits-primary-endpoint-in-phase-2-endometrial-cancer BioNTech ADC Trastuzumab Pamirtecan Hits Primary Endpoint in Phase 2 Endometrial Cancer Trial |... Phase 2 cohort for trastuzumab pamirtecan met primary endpoints with 48% confirmed objective response rate in centrally tested patients with recurrent... primary endpointendometrial cancerbiontechadchits https://www.fiercebiotech.com/biotech/sage-tweaks-primary-endpoint-for-zuranolone-depression-trial-leaving-key-durability Sage tweaks primary endpoint for zuranolone depression trial, leaving key durability question... Nov 2, 2021 - Sage Therapeutics has slightly tweaked the primary endpoint for a phase 3 trial of the Biogen-partnered depression drug zuranolone, a move analysts say is... primary endpointsagetweakszuranolonedepression https://health.economictimes.indiatimes.com/news/pharma/research-development/biontechs-cancer-drug-meets-primary-endpoint-in-phase-2-trial/112140756 COVID-19 Vaccine Maker: BioNTech's cancer drug meets primary endpoint in Phase 2 trial,... COVID-19 Vaccine Maker: The trial met its primary endpoint, with data demonstrating a statistically significant improvement in the overall response rate in... primary endpointcovidvaccinemakerbiontech https://www.chemdiv.com/company/media/pharma-news/2026/roche-s-phase-iii-trial-of-fenebrutinib-in-rms-meets-primary-endpoint/ Roche's Phase III Trial of Fenebrutinib in RMS Meets Primary Endpoint Roche reports its Phase III FENhance 1 trial for fenebrutinib in relapsing multiple sclerosis met its primary endpoint, reducing... phase iii trialprimary endpointrochefenebrutinibrms https://rss.globenewswire.com/fr/news-release/2025/02/03/3019385/0/en/GH-Research-Announces-Primary-Endpoint-Met-in-Phase-2b-Trial-with-GH001-in-TRD-Demonstrating-15-5-Point-Placebo-adjusted-MADRS-Reduction.html GH Research Announces Primary Endpoint Met in Phase 2b Primary endpoint met, GH001 led to an ultra-rapid anti-depressant effect with a significant placebo-adjusted MADRS reduction from baseline of -15.5 on Day... primary endpointghresearchannouncesmet https://www.news-medical.net/news/2009/03/11/46787.aspx Study of Rituxan (rituximab) in lupus nephritis misses primary endpoint Jun 20, 2019 - Genentech, Inc. and Biogen Idec has announced that a Phase III study of Rituxan (rituximab) plus mycophenolate mofetil (MMF) and corticosteroids in patients... lupus nephritisprimary endpointstudymisses https://medicaex.com/prnewswire/akesos-cadonilimab-pd-1-ctla-4-phase-iii-trial-meets-primary-endpoint-at-interim-analysis-demonstrating-strong-overall-survival-benefit-as-first-line-treatment-in-all-comer-patients-with-gastric/ Akeso's Cadonilimab (PD-1/CTLA-4) Phase III Trial Meets Primary Endpoint at Interim Analysis... Nov 13, 2023 - HONG KONG, Nov. 7, 2023 /PRNewswire/ -- Akeso (9926.HK) announced positive results from an interim analysis of AK104-302 study, a randomized, double-blind,... phase iii trialprimary endpointakesopdmeets https://pharmaphorum.com/news/ema-backs-sv95c-digital-primary-endpoint-dmd-trials EMA backs SV95C as digital primary endpoint for DMD trials | pharmaphorum primary endpointemabacksdigitaldmd https://www.tikr.com/pt/blog/grail-nasdaq-gral-stock-crater-47-after-cancer-drug-trial-fails-to-meet-primary-endpoint Grail Stock Craters 47% After Cancer Drug Trial Fails To Meet Primary Endpoint | TIKR.com Feb 24, 2026 - GRAIL stock plunges 47% after its massive cancer screening trial misses primary endpoint, raising questions about FDA approval and Medicare coverage prospects. after cancerprimary endpointgrailstockcraters https://www.ophthalmologymanagement.com/news/2025/aldeyra-therapeutics-achieves-primary-endpoint-in-phase-3-ded-chamber-trial-of-reproxalap/ Aldeyra Therapeutics Achieves Primary Endpoint in Phase 3 DED Chamber Trial of Reproxalap |... May 7, 2025 - Conexiant Vision: Delivering trusted clinical content, deep audience engagement, and educational resources for eye care professionals. Discover more through... primary endpointtherapeuticsphasededchamber https://ecancer.org/en/news/19536-wclc-2020-lcmc3-neoadjuvant-atezolizumab-safe-meets-primary-endpoint-of-pathologic-response-rate WCLC 2020: LCMC3: Neoadjuvant atezolizumab safe, meets primary endpoint of pathologic response rate... Primary analysis of the Lung Cancer Mutation Consortium (LCMC) 3 study revealed that neoadjuvant atezolizumab prior to lung cancer surgery was well tolerated primary endpointresponse ratewclcsafemeets https://wiseek.ai/ticker/lpcn/lipocine-s-lead-ppd-candidate-fails-phase-3-primary-endpoint-raises-12m-via-highly-dilutive-atm-offering-000149315226021637/ Lipocine's Lead PPD Candidate Fails Phase 3 Primary Endpoint; Raises $12M via Highly Dilutive ATM... May 7, 2026 - Lipocine Inc. reported a significant increase in net loss for Q1 2026 and announced that its lead postpartum depression (PPD) candidate, LPCN 1154. primary endpointleadppdcandidatefails https://salesandmarketingnetwork.com/news_release_bs.html?pipe=0000ac177000191&ID=2040763&key=blinatumomab News for Medical Sales Reps: Phase 3 Study of BLINCYTO(R) (Blinatumomab) Met Primary Endpoint Of... for medicalsales repsprimary endpointnewsphase https://www.gsk.com/en-gb/media/press-releases/phase-iii-captain-study-of-trelegy-ellipta-in-patients-with-asthma-meets-primary-endpoint/ Phase III CAPTAIN study of Trelegy Ellipta in patients with asthma meets primary endpoint | GSK Phase III CAPTAIN study of Trelegy Ellipta in patients with asthma meets primary endpoint phase iiitrelegy elliptain patientsprimary endpointcaptain https://www.talk.bio/2025/06/corcept-highlights-survival-benefit.html Corcept Highlights Survival Benefit Despite ALS Trial's Missed Primary Endpoint primary endpointhighlightssurvivalbenefitdespite https://in.marketscreener.com/news/tozorakimab-met-primary-endpoint-in-both-oberon-and-titania-phase-iii-trials-in-patients-with-copd-ce7e51dbdf8bf122 Tozorakimab met primary endpoint in both OBERON and TITANIA Phase III trials in patients with COPD... Mar 27, 2026 - First-ever IL-33-targeting biologic to demonstrate statistically significant and highly clinically meaningful reductions in COPD exacerbations in two replicate... primary endpointphase iiimetoberontitania https://gabionline.net/es/biosimilares/investigacion/Phase-III-study-of-biosimilar-adalimumab-meets-primary-endpoint Phase III study of biosimilar adalimumab meets primary endpoint Biologicals major Amgen announced on 8 October 2014 the first late-stage data from its biosimilars programme. Primary efficacy analysis from a phas... phase iiiprimary endpointstudybiosimilaradalimumab https://igmpi.ac.in/news/clinical-research/phase-iii-thyroid-eye-disease-trial-of-innovent-fulfils-primary-endpoint Phase III thyroid eye disease trial of Innovent fulfils primary endpoint Phase III thyroid eye disease trial of Innovent fulfils primary endpoint thyroid eye diseasephase iiiprimary endpointtrial https://xagena.it/news/medicinenews_net_farmaci/68be68a4c8ce0d9d97e5259a649ce6a4.html TRINOVA-1 trial: Trebananib in recurrent ovarian cancer study meets primary endpoint of... Amgen has announced that the Phase 3 TRINOVA-1 trial evaluating Trebananib plus Paclitaxel versus placebo plus Paclitaxel in recurrent ovarian ... recurrent ovarian cancerprimary endpointtrinovatrialstudy https://www.ucviden.dk/en/publications/blinded-interpretation-of-the-primary-endpoint-results-from-the-s/ Blinded Interpretation of The Primary Endpoint Results From The Study: "An Individualised Treatment... primary endpointresults frominterpretationstudytreatment https://pressreleasehub.pa.media/article/imlifidase-successfully-meets-primary-endpoint-in-pivotal-us-phase-3-confides-trial-in-kidney-transplantation-55404.html Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney... primary endpointsuccessfullymeetspivotalus https://www.takeda.com/newsroom/newsreleases/2019/phase-3-trial-of-ninlaro-ixazomib-as-first-line-maintenance-therapy-met-primary-endpoint-in-multiple-myeloma-patients-not-treated-with-stem-cell-transplantation/ Phase 3 Trial of NINLAROTM (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in... Phase 3 Trial of NINLARO (ixazomib) as First Line Maintenance Therapy Met Primary Endpoint in Multiple Myeloma Patients not treated with Stem Cell... first linemaintenance therapyprimary endpointphasetrial https://www.merck.com/news/merck-announces-phase-3-keynote-355-trial-met-primary-endpoint-of-overall-survival-os-in-patients-with-metastatic-triple-negative-breast-cancer-whose-tumors-expressed-pd-l1-cps-%E2%89%A510/ Merck Announces Phase 3 KEYNOTE-355 Trial Met Primary Endpoint of Overall Survival (OS) in Patients... Apr 17, 2026 - KEYTRUDA Is the First Anti-PD-1 Therapy in Combination With Chemotherapy to Show Statistically Significant OS for This Patient Population Merck (NYSE: MRK),... primary endpointmerckannouncesphasekeynote https://fightec.org/astellas-announces-zolbetuximab-meets-primary-endpoint-in-phase-3-glow-trial-as-first-line-treatment-in-claudin-18-2-positive-her2-negative-locally-advanced-unresectable-or-metastatic-gastric-and-gas/ Astellas Announces Zolbetuximab Meets Primary Endpoint in Phase 3 GLOW Trial as First-Line... primary endpointfirst lineannouncesmeetsphase https://www.bostonscientific.com/en-EU/medical-specialties/interventional-cardiology/clinical-spotlight/platinum-diversity-trial-primary-endpoint.html PLATINUM Diversity Trial - Primary Endpoint - Boston Scientific primary endpointboston scientificplatinumdiversitytrial https://www.canceropole-est.org/la-recherche-au-sein-du-canceropole-est/annuaires/publications-scientifiques/detail/?id=691 Health-related quality-of-life as co-primary endpoint in randomized clinical trials in oncology. -... quality of lifehealth relatedprimary endpointclinical trialsco https://www.biopharmaapac.com/news/26/7754/aroa-biosurgery-reports-positive-primary-endpoint-achievement-in-symphony-rct-for-diabetic-foot-ulcers.html Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot... Aroa Biosurgery Reports Positive Primary Endpoint Achievement In Symphony RCT For Diabetic Foot Ulcers aroa biosurgeryprimary endpointdiabetic footreportspositive https://www.prnewswire.com/news-releases/taihos-tas-102-meets-primary-endpoint-of-improving-overall-survival-in-phase-iii-terra-study-in-asian-patients-with-refractory-metastatic-colorectal-cancer-300244624.html Taiho's TAS-102 Meets Primary Endpoint of Improving Overall Survival in Phase III TERRA Study in... /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. of Tokyo announced on April 1 results from its Phase III TERRA study on its oral combination anticancer drug... primary endpointphase iiitasmeetsimproving https://www.cis.lmu.de/schuetze/e/e/ep/epr/epri/eprim/eprima/OtHeR/eprimary_efficacy_endpoint.html primary efficacy endpoint primaryefficacyendpoint